Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Anaptysbio (ANAB) Accumulated Depreciation & Amortization: 2016-2025

Historic Accumulated Depreciation & Amortization for Anaptysbio (ANAB) over the last 10 years, with Sep 2025 value amounting to $140,000.

  • Anaptysbio's Accumulated Depreciation & Amortization fell 2.78% to $140,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $573,000, marking a year-over-year decrease of 8.47%. This contributed to the annual value of $606,000 for FY2024, which is 7.06% down from last year.
  • Anaptysbio's Accumulated Depreciation & Amortization amounted to $140,000 in Q3 2025, which was down 1.41% from $142,000 recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Accumulated Depreciation & Amortization peaked at $184,000 during Q4 2022, and registered a low of $125,000 during Q1 2021.
  • Over the past 3 years, Anaptysbio's median Accumulated Depreciation & Amortization value was $154,000 (recorded in 2024), while the average stood at $153,273.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first rose by 29.60% in 2022, then fell by 12.12% in 2024.
  • Over the past 5 years, Anaptysbio's Accumulated Depreciation & Amortization (Quarterly) stood at $165,000 in 2021, then grew by 11.52% to $184,000 in 2022, then dropped by 10.33% to $165,000 in 2023, then fell by 12.12% to $145,000 in 2024, then fell by 2.78% to $140,000 in 2025.
  • Its last three reported values are $140,000 in Q3 2025, $142,000 for Q2 2025, and $146,000 during Q1 2025.